FDA Inspection 1019098 — Pavel Navratil, M.D. CI
The FDA completed an inspection of Pavel Navratil, M.D. CI on May 19, 2017 in Prostejov 4. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 19, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Prostejov 4 (Czech Republic)
Additional Details
Clinical Investigator (CI)